Encysive shares up on FDA review of blood pressure drug
Shares of Encysive Pharmaceuticals Inc. jumped Thursday after the company said the Food and Drug Administration is reviewing its drug to treat high blood pressure in the pulmonary arteries, a condition called pulmonary arterial hypertension.
